Table 1.
Baseline characteristics | n=954 |
---|---|
Age, years | 33.4±5.9 |
Age group, n (%) | |
18–35 years | 624 (65.4) |
36–50 years | 330 (34.6) |
Weight, kg | 56.55±8.04 |
Height, cm | 160.40±4.88 |
BMI, kg/m2 | 21.91±2.86 |
Country/region, n (%) | |
China | 686 (71.9) |
Hong Kong | 36 (3.8) |
India | 16 (1.7) |
Thailand | 92 (9.6) |
Taiwan | 124 (13.0) |
Smoking history, n (%) | |
Never | 929 (97.4) |
Former | 6 (0.6) |
Current | 19 (2.0) |
Alcohol use, n (%) | |
Abstinent | 853 (89.4) |
Light | 99 (10.4) |
Moderate | 2 (0.2) |
Medical history, n (%) | |
Surgical and medical procedures | 376 (39.4) |
Reproductive system and breast disorders | 120 (12.6) |
Pregnancy, puerperium, and perinatal conditions | 113 (11.8) |
Infections and infestations | 85 (8.9) |
Neoplasms benign, malignant and unspecified (incl. cysts and polyps) | 52 (5.5) |
Gastrointestinal disorders | 30 (3.1) |
Immune system disorders | 29 (3.0) |
Others | 149 (15.7) |
Gynecological history | |
Age at menarche, years | 13.4±1.5 |
Average duration of menstrual bleeding, days | 5.3±1.4 |
Average length of cycle, days | 29.4±2.9 |
Number of abortions | 1.2±1.5 |
Amenorrhea during last 6 months, n (%) | 5 (0.5) |
Intracyclic bleeding during last 6 months, n (%) | 18 (1.9) |
Dysmenorrhea during last 6 months, n (%) | 155 (16.2) |
Prior/concomitant therapy, n (%) | |
Genitourinary system and sex hormones | 225 (23.6) |
Alimentary tract and metabolism | 44 (4.6) |
Anti-infectives for systemic use | 44 (4.6) |
Dermatological | 35 (3.7) |
Respiratory system | 28 (2.9) |
Sensory organs | 27 (2.8) |
Nervous system | 26 (2.7) |
Others | 528 (55.1) |
Notes: All values are presented as mean±SD unless otherwise stated.
Abbreviations: BMI, body mass index; incl., including.